A rare case of primary non-metastatic Non-Hodgkin's diffuse large B-cell lymphoma in the ileum in a 19-year-old male manifested as intestinal obstruction- A case report

被引:2
作者
Albrijawy, Reham [1 ,2 ,3 ]
Al Laham, Omar [1 ,2 ,3 ]
Shaheen, Jack [1 ,2 ,3 ]
Atia, Fareed [1 ,2 ,3 ]
Alshiekh, Ali [1 ]
机构
[1] Al Mouwasat Univ Hosp, Dept Surg, Damascus, Syria
[2] Al Assad Univ Hosp, April 17th St Kafar Sousah, Damascus, Syria
[3] Al Mouwasat Univ Hosp, Damascus, Syria
来源
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS | 2022年 / 90卷
关键词
Case report; Intestinal lymphoma; Primary Beal Non-Hodgkin's lymphoma; Diffuse large B-cell lymphoma; Intestinal obstruction; Surgical abdomen; CLINICAL-FEATURES;
D O I
10.1016/j.ijscr.2021.106748
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction and importance: The gastrointestinal system is the most common site for extra-nodal NHL. Adolescent population are among the rarest of compromised groups, especially males. The gastrointestinal system is more involved by secondary metastasis rather than by primary lymphomas. Cardinal B-Symptoms and obstipation constituted the presentation of our patient who was diagnosed postoperatively as a case primary non-metastatic NHL. NHL can have misleading presentations which result in the implementation of different treatment modalities. We ought to have high clinical suspicion when presented with a patient suffering from B-Symptoms and obstipation to make timely judgements which help in performing effective therapeutic interventions to limit the morbidity and mortality which result from this pathology. Case presentation: We present the case of a 19-year-old male, who presented with obstipation and B-Symptoms. CT scan indicated loop dilation, a lobulated mass, and what radiologically seemed to be intussusception. Surgery was done and the resected specimens were DLBCL. Clinical discussion: We treated him by surgical excision of the affected ileal segments. Histopathology indicated a primary Non-Hodgkin's DLBCL of the ileum. Afterwards, we referred him for adjuvant chemotherapy. Treatment modalities for this malignancy are mainly surgical in addition to Chemotherapy. Conclusion: Intestinal extranodal NHL presents with an array of vague symptoms. As a result, this type of tumors can be clinically indistinguishable from other gastrointestinal malignancies. It is vital to keep this type of malignancy in mind as a differential diagnosis when presented with a surgical abdomen in a patient with B-Symptoms.
引用
收藏
页数:6
相关论文
共 44 条
  • [41] Clinical use of HD-MTX monotherapy in a rare case of refractory primary bone diffuse large B-cell lymphoma with long-term survival after local radiotherapy: A case report
    Wu, Zhiya
    Teng, Yue
    Wu, Jianqiu
    Zhang, Honglu
    Peng, Weiwei
    Meng, Cheng
    Tang, Weiyan
    Feng, Jifeng
    FRONTIERS IN MEDICINE, 2022, 9
  • [42] Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
    W Klapper
    H Stoecklein
    S Zeynalova
    G Ott
    F Kosari
    A Rosenwald
    M Loeffler
    L Trümper
    M Pfreundschuh
    Reiner Siebert
    Leukemia, 2008, 22 : 2226 - 2229
  • [43] Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
    Klapper, W.
    Stoecklein, H.
    Zeynalova, S.
    Ott, G.
    Kosari, F.
    Rosenwald, A.
    Loeffler, M.
    Truemper, L.
    Pfreundschuh, M.
    Siebert, Reiner
    LEUKEMIA, 2008, 22 (12) : 2226 - 2229
  • [44] To evaluate prognostic significance of metabolic-derived tumour volume at staging 18-flurodeoxyglucose PET-CT scan and to compare it with standardized uptake value-based response evaluation on interim 18-flurodeoxyglucose PET-CT scan in patients of non-Hodgkin's lymphoma (diffuse large B-cell lymphoma)
    Gupta, Nitin
    Singh, Natasha
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (04) : 395 - 404